The T2A or T arifi A the A ctivity is the financing of health facilities, whether public or private, whose implementation started in 1 January 2004.
This financing method is called to replace, gradually over a period of ten years, the two funding methods hitherto in force:
- the block grant for public schools and participating in public service (DPPP)
- Pricing by the day and performed the act for private clinics.
The main principle of the T2A is to tie funding directly to the activity (medical or surgical) of the institution, up or down. The activity is identified through the notion of stay of patients in the facility. Each residence is a homogenous group living (GHS) which applies a tariff. Terms of additional funding in addition to complex cases and for activities not described in the GHS (research or teaching for example).
costs of drugs and medical devices are normally included in the rates of GHS. However, some of them, when they are very expensive, introducing a heterogeneity in the package stay (GHS).
A limited list of drugs and medical devices that are in this case is established by the Ministry of Health. These products are called "off-GHS" and give rise to an invoice in addition to social security, at a maximum rate fixed by regulation (Ministerial Order for Proprietary Medicinal Products, the ISL costs for medical devices.). These lists are updated at least once a year.